Patent: 10,639,333
✉ Email this page to a colleague
Summary for Patent: 10,639,333
| Title: | Process for removing growth factors from platelets |
| Abstract: | In vitro and in vivo application of sub-atmospheric, negative pressure on growth factor starting material, such as whole blood, extracts growth factors from the platelet granules of the growth factor starting material in a non-destructive medium without activating the clotting process. The extracted growth factors are released into a growth factor composition containing blood plasma, extracellular fluid or interstitial fluid depending upon the type and location of the growth factor starting material. The growth factors have a weight of about 70-76 kDaltons and are applied in either a filtered or unfiltered state topically to the area of a surface wound to effect healing. The extracted growth factors are also injected into soft tissue, such as a torn tendon, to promote tissue growth and healing. The growth factors are released in one method from a patient\'s own blood. In another method the growth factors are released from a whole blood source and freeze dried by lyophilization. Then at a later date, the freeze-dried product is reconstituted by normal saline for treatment of a patient\'s wound, for use in a surgical procedure, or for tissue regeneration. |
| Inventor(s): | Nelson; Gary H. (Fort Myers, FL), Brandt; Ryan N (Fort Myers, FL), Galen; Clark (Sarasota, FL), Kiwczak; John (Sarasota, FL) |
| Assignee: | |
| Application Number: | 15/700,084 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,639,333
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Octapharma Pharmazeutika Produktionsges.m.b.h. | CUTAQUIG | immune globulin subcutaneous (human)-hipp | Solution | 125668 | 12/12/2018 | ⤷ Try a Trial | 2029-07-09 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
